The European Commission (EC) Thursday signed the agreement that will seal the agreement to acquire 1.8 billion doses of Pfizer.
This already was announced in April with Pfizer-BioNTech to buy 900 million vaccines against the coronavirus between the end of 2021 and 2023, with the option of an additional 900 million, according to the Community Executive.
The agreement stipulates that from 2022 the delivery of vaccines is guaranteed, requires that their production is in the European Union (EU) and that the essential components to manufacture it are also obtained in community territory.
It also reinforces the possibility that EU countries currently have to resell or donate leftover doses to third countries or through the COVAX initiative.
“ Production and delivery to the EU of up to 1.8 billion doses are guaranteed. Potential contracts with other producers will follow the same win-win model, ”wrote the president of the EC, Ursula Von der Leyen, on her official Twitter account.
Health Commissioner Stella Kyriakides added that it is necessary to “stay one step ahead of the virus.” “This implies having access to adapted vaccines to protect against the threat of variants,” he added.
When he announced the agreement, Von der Leyen said that Brussels had opted to renew the agreement with Pfizer-BioNTech because of the guarantees it offers in compliance with the current contract and because its vaccine is based on the new messenger RNA technology.
The objective is to have enough vaccines to be able to combat the variants and to be able to face the vaccination of minors, as well as to have a possible third dose in the coming years.
On the other hand, Von der Leyen assured that by the end of this week the European Union will distribute a total of 260 million vaccines that are already available, and described the immunization campaign as a “success”.
“In this way, half of the adults in Europe can be vaccinated, ” said the German, who acknowledged that although at the beginning of the vaccination the EU was able to observe countries such as the United States or the United Kingdom “with envy”, which What matters is “the big picture.”
The president of the EC affirmed that 200 million Europeans have already been inoculated and insisted that the advance that other countries initially had over the EU in vaccinating against the COVID-19 disease must be “relativized”.
Von der Leyen defended that the EU managed to recover the initial delay in vaccinations and insisted that it has not only managed to supply doses for its own population, but also to export (about 260 million) to other countries.
“We have to be proud,” insisted the official, while ensuring that the EU is willing to “make easier” the transfer of knowledge in relation to the manufacture of vaccines, although it did not pronounce on the possibility of a temporary suspension patent.
(With information from EFE)